David Digomann - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

David Digomann

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

JCI Insight|December 9, 2025

Nectin-4 reduces T cell effector function and is a therapeutic target in pancreatic cancerMax Heiduk, Carolin Beer, Sarah Cronjaeger, et al.

Iscience|December 1, 2025

Soluble TIM-3 and galectin-9 predict survival in gastric and gastroesophageal junction cancerDavid Digomann, Charlotte Reiche, Antonia Stammberger, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2019

The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma RadiosensitivityDavid Digomann, Ina Kurth, Anna Tyutyunnykova, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

JCI Insight|December 9, 2025

Nectin-4 reduces T cell effector function and is a therapeutic target in pancreatic cancerMax Heiduk, Carolin Beer, Sarah Cronjaeger, et al.

Iscience|December 1, 2025

Soluble TIM-3 and galectin-9 predict survival in gastric and gastroesophageal junction cancerDavid Digomann, Charlotte Reiche, Antonia Stammberger, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2019

The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma RadiosensitivityDavid Digomann, Ina Kurth, Anna Tyutyunnykova, et al.

Pageof 2